ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,187,440 | $792,982 | $396,406 | $570,162 |
| - Cash | $49,668 | $75,864 | $49,334 | $59,406 |
| + Debt | $0 | $3,273 | $3,213 | $9,357 |
| Enterprise Value | $1,137,772 | $720,391 | $350,285 | $520,113 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$304 |
| % Margin | – | – | – | – |
| EBITDA | -$32,299 | -$38,754 | -$32,416 | -$36,003 |
| % Margin | – | – | – | – |
| Net Income | -$32,587 | -$36,355 | -$30,021 | -$36,307 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.33 | -0.47 | -0.42 | -0.51 |
| % Growth | 29.8% | -11.9% | 17.6% | – |
| Operating Cash Flow | -$25,112 | -$30,842 | -$32,775 | -$28,054 |
| Capital Expenditures | -$35 | -$63 | -$387 | -$219 |
| Free Cash Flow | -$25,147 | -$30,905 | -$33,162 | -$28,273 |